Harnessing The Immunomodulatory Capacity Of Dendritic Cells Differentiated From Human Induced Pluripotent Stem Cells And The Therapeutic Potential Of Dendritic Cell-Derived Exosomes For The Treatment Of Lysosomal Storage Diseases